Download PPT - Altogen Biosystems

Leading Developer and Manufacturer of In Vivo and DNA Transfection
Kits, Transfection Reagents and Electroporation Delivery Products
Products > Transfection Reagent for Calu-6 Cells (Lung Carcinoma Cell, HTB-56)
Altogen Biosystems offers the Calu-6 Transfection Reagent
among a host of 100+ cell line specific In Vitro Transfection Kits.
The Calu-6 Transfection Reagent is an advanced liposome
formulation that enhances lipid mediated transfection, and it has
been developed to provide high transfection efficiency with Calu-6
cells.
This cell line is a good host for studying lung cancer. When
cultured in vitro, Calu-6 cells are a monolayer and adhere to the
surface of the culture flask.
Other applications include drug discovery, gene expression
studies, molecular and cell biology research applications.
Purchase Calu-6 Transfection Kit at www.Altogen.com
Altogen Biosystems  848 Rainbow Blvd #823  Las Vegas  NV  89107  USA
Telephone  702 349 6103  Fax  702 989-0841  email  [email protected]
Leading Developer and Manufacturer of In Vivo and DNA Transfection
Kits, Transfection Reagents and Electroporation Delivery Products
Products > Transfection Reagent for Calu-6 Cells (Lung Carcinoma Cell, HTB-56)
Calu-6 Cell Line Description and Applications
Calu-6
http://www.nexcelom.com/
The Calu-6 cell line is a lung carcinoma cell line that was
established from the tissue of a 61 year-old Caucasian
female patient with lung cancer (anaplastic carcinoma).
The Calu-6 cell line has a modal chromosome number of
59 and displays epithelial morphology. This cell line has
shed light on the relationship between lung cancer cells
and antimycin A.
Research studies reflect the possibility of a correlation
between reactive oxygen species and glutathione and
apoptosis of antimycin A-treated Calu-6 cells.
The Calu-6 cell also has applications for studying the
renin-angiotensin system via studying mechanical stretch
in relation to pressure transduction on the release of
renin.
Altogen Biosystems  848 Rainbow Blvd #823  Las Vegas  NV  89107  USA
Telephone  702 349 6103  Fax  702 989-0841  email  [email protected]
Leading Developer and Manufacturer of In Vivo and DNA Transfection
Kits, Transfection Reagents and Electroporation Delivery Products
Products > Transfection Reagent for Calu-6 Cells (Lung Carcinoma Cell, HTB-56)
Calu-6 Transfection Protocol
1. Plate 10,000 - 15,000 Calu-6cells per well in 0.5 ml of complete growth medium 12–24 hours prior to
transfection
2. Wash with 1xPBS and add 0.5 ml of fresh growth medium
3. Prepare transfection complexes by mixing 40 µl of serum-free medium, 5.5 µl of transfection reagent,
and
• 750 ng DNA (or mRNA), or
• 30 nM - 50 nM of siRNA (or microRNA)
*Referred to a final volume including growth medium
4. Incubate transfection complexes at RT for 15 - 30 minutes
5. Optional: Add 2 µl of Complex Condenser. This reagent reduces the size of transfection complex,
therefore increasing transfection efficiency; however it may increase cell toxicity
6. Add prepared transfection complexes to 0.5 ml of complete growth medium with Calu-6 cells (from step
2)
7. Incubate cells at 37ºC in a humidified CO2 incubator
8. Assay for phenotype or target gene expression 48 - 72 hours after transfection
Optional: Transfection efficiency can be increased by addition of Transfection Enhancer reagent. Add 2 µl of
Transfection Enhancer reagent 12-24 hours after transfection
If the viability of Calu-6 cells being transfected is affected at 16 - 24 hours post-transfection, the level of cytotoxicity
can be decreased by changing the growth medium and eliminating redundant exposure of cells to transfectant
Altogen Biosystems  848 Rainbow Blvd #823  Las Vegas  NV  89107  USA
Telephone  702 349 6103  Fax  702 989-0841  email  [email protected]
Leading Developer and Manufacturer of In Vivo and DNA Transfection
Kits, Transfection Reagents and Electroporation Delivery Products
Products > Transfection Reagent for Calu-6 Cells (Lung Carcinoma Cell, HTB-56)
General Lipoplex-mediated Transfection Mechanism of Action
Altogen Biosystems  848 Rainbow Blvd #823  Las Vegas  NV  89107  USA
Telephone  702 349 6103  Fax  702 989-0841  email  [email protected]
Leading Developer and Manufacturer of In Vivo and DNA Transfection
Kits, Transfection Reagents and Electroporation Delivery Products
Products > Transfection Reagent for Calu-6 Cells (Lung Carcinoma Cell, HTB-56)
Calu-6 Transfection Kit Product Details
•
Two component formulation enhances lipid mediated transfection efficiency
•
Optimized easy-to-use transfection protocol provided for transfection of siRNA, DNA,
mRNA, and microRNA
•
Kit includes Transfection Enhancer reagent and recommended transfection protocol
•
High transfection efficacy in the presence of serum
•
Expand your RNAi application with a reagent optimized for delivery of both siRNA and
plasmid
•
Reproducible transfection results
•
Works well for standard reverse transfection and high-throughput applications
Developed and manufactured by Altogen Biosystems (www.Altogen.com)
Altogen Biosystems  848 Rainbow Blvd #823  Las Vegas  NV  89107  USA
Telephone  702 349 6103  Fax  702 989-0841  email  [email protected]
Leading Developer and Manufacturer of In Vivo and DNA Transfection
Kits, Transfection Reagents and Electroporation Delivery Products
Products > Transfection Reagent for Calu-6 Cells (Lung Carcinoma Cell, HTB-56)
Data
Figure 1. GAPD mRNA levels were quantified using real-time RT-PCR in the Calu-6 cells transfected
with siRNAs targeting GAPD or non-silencing siRNA. Forty-eight hours post-transfection, the cells
were harvested and analyzed by real-time RT-PCR for GAPDH mRNA expression levels. Data were
normalized against the 18S rRNA signal. Control samples were either mock-transfected or untreated.
Values are normalized to untreated sample. Data are means ± SD (n=3).
Leading Developer and Manufacturer of In Vivo and DNA Transfection
Kits, Transfection Reagents and Electroporation Delivery Products
Products > Transfection Reagent for Calu-6 Cells (Lung Carcinoma Cell, HTB-56)
Data
Figure 2. Protein expression of GAPDH in Calu-6 cells. DNA plasmid expressing GAPDH or siRNA targeting
GAPDH were transfected into Calu-6 cells following Altogen Biosystems transfection protocol. At 72 hours posttransfection the cells were analyzed by Western Blot for protein expression levels (normalized by total protein,
10 µg of total protein loaded per each well). Untreated cells used as a negative control.
Leading Developer and Manufacturer of In Vivo and DNA Transfection
Kits, Transfection Reagents and Electroporation Delivery Products
Products > Transfection Reagent for Calu-6 Cells (Lung Carcinoma Cell, HTB-56)
Calu-6 Transfection Kit Benefits
• Pre-optimized transfection protocol for Calu-6 cell line
• Compatible with DNA, small RNA (siRNA, shRNA, miRNA), mRNA, and small protein complexing
• Free of serum and protein of animal origin
• Compatible with standard and reverse transfection methods (both protocols provided in the kit manual)
• Easy to use Calu-6 transfection protocol ensures great performance with expedited experimental timeline
• Equally efficient for single or multiple transfections
• Can be used for transient transfection and development of stable Calu-6 cell lines
• Bio-degradable after endocytosis
• Used for preclinical research worldwide
Altogen Biosystems  848 Rainbow Blvd #823  Las Vegas  NV  89107  USA
Telephone  702 349 6103  Fax  702 989-0841  email  [email protected]